Treatment of hypertension in Germany: is there a social gradient?

Laaser U, Breckenkamp J, Bjegovic V (2012)
International Journal of Public Health 57(1): 185-191.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ;
Abstract / Bemerkung
Effective hypertension control remains low without much improvement since the 1990s. However, information is limited whether and how social status impacts on hypertension control. Data from the German Health Survey 1998 are used to explore the role of social status according to educational achievement in treating hypertension, adjusted for key determinants in a logistic regression. Actual as well as population prevalence (a parts per thousand yen140 mmHg/a parts per thousand yen90 mmHg) is highest in the lowest of the three social classes with 59.4 and 51.9% as compared to 44.5 and 40.5% in the highest. Physician contacts during the previous year were also highest in the lower class with 76.0% as compared to 59.0% in the highest. The logistic regression revealed insignificant odds ratios (OR) of 1.46 for the highest and 1.12 for the middle class for treatment of known hypertension after adjusting for gender (OR for females, 1.38), age (OR for 60-69 years, 13.13), GP visits (OR, 1.43) and living in East Germany (OR, 1.56). German survey data for antihypertensive treatment do not show any significant disadvantage for the lowest social class.
Erscheinungsjahr
Zeitschriftentitel
International Journal of Public Health
Band
57
Zeitschriftennummer
1
Seite
185-191
ISSN
eISSN
PUB-ID

Zitieren

Laaser U, Breckenkamp J, Bjegovic V. Treatment of hypertension in Germany: is there a social gradient? International Journal of Public Health. 2012;57(1):185-191.
Laaser, U., Breckenkamp, J., & Bjegovic, V. (2012). Treatment of hypertension in Germany: is there a social gradient? International Journal of Public Health, 57(1), 185-191. doi:10.1007/s00038-011-0274-4
Laaser, U., Breckenkamp, J., and Bjegovic, V. (2012). Treatment of hypertension in Germany: is there a social gradient? International Journal of Public Health 57, 185-191.
Laaser, U., Breckenkamp, J., & Bjegovic, V., 2012. Treatment of hypertension in Germany: is there a social gradient? International Journal of Public Health, 57(1), p 185-191.
U. Laaser, J. Breckenkamp, and V. Bjegovic, “Treatment of hypertension in Germany: is there a social gradient?”, International Journal of Public Health, vol. 57, 2012, pp. 185-191.
Laaser, U., Breckenkamp, J., Bjegovic, V.: Treatment of hypertension in Germany: is there a social gradient? International Journal of Public Health. 57, 185-191 (2012).
Laaser, Ulrich, Breckenkamp, Jürgen, and Bjegovic, Vesna. “Treatment of hypertension in Germany: is there a social gradient?”. International Journal of Public Health 57.1 (2012): 185-191.

3 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Determinants of Uncontrolled Hypertension in Rural Communities in South Asia-Bangladesh, Pakistan, and Sri Lanka.
Jafar TH, Gandhi M, Jehan I, Naheed A, de Silva HA, Shahab H, Alam D, Luke N, Wee Lim C, COBRA-BPS Study Group., Am J Hypertens 31(11), 2018
PMID: 29701801
Living with Hypertension: A Qualitative Research.
Shamsi A, Dehghan Nayeri N, Esmaeili M., Int J Community Based Nurs Midwifery 5(3), 2017
PMID: 28670584

40 References

Daten bereitgestellt von Europe PubMed Central.


BM, Das Gesundheitswesen 60(Sonderheft 2), 1998
Trends and social factors in blood pressure control in Scottish MONICA surveys 1986-1995: the rule of halves revisited.
Chen R, Tunstall-Pedoe H, Morrison C, Connaghan J, A'Brook R., J Hum Hypertens 17(11), 2003
PMID: 14578914

R, J Hypertens 22(6), 2004
Socio-economic status and blood pressure: an overview analysis.
Colhoun HM, Hemingway H, Poulter NR., J Hum Hypertens 12(2), 1998
PMID: 9504351
Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries.
Dalstra JA, Kunst AE, Borrell C, Breeze E, Cambois E, Costa G, Geurts JJ, Lahelma E, Van Oyen H, Rasmussen NK, Regidor E, Spadea T, Mackenbach JP., Int J Epidemiol 34(2), 2005
PMID: 15737978
Socioeconomic inequalities in hypertension prevalence and care: the IHPAF Study.
de Gaudemaris R, Lang T, Chatellier G, Larabi L, Lauwers-Cances V, Maitre A, Diene E., Hypertension 39(6), 2002
PMID: 12052852

AUTHOR UNKNOWN, 0

H, 1992
Prevalence, awareness, treatment, control and risk factors of hypertension in Korea: the Ansan study.
Jo I, Ahn Y, Lee J, Shin KR, Lee HK, Shin C., J. Hypertens. 19(9), 2001
PMID: 11564970
Functional health literacy among primary health-care patients: data from the Belgrade pilot study.
Jovic-Vranes A, Bjegovic-Mikanovic V, Marinkovic J., J Public Health (Oxf) 31(4), 2009
PMID: 19454605
Ostrava--a new endemic focus of Mycobacteria xenopi in the Czech Republic.
Kaustova J, Charvat B, Mudra R, Holendova E., Cent. Eur. J. Public Health 1(1), 1993
PMID: 8305886
Results of the Ontario survey on the prevalence and control of hypertension.
Leenen FH, Dumais J, McInnis NH, Turton P, Stratychuk L, Nemeth K, Moy Lum-Kwong M, Fodor G., CMAJ 178(11), 2008
PMID: 18490640
[Epidemiology of hypertension in Germany. Selected results of population-representative cross-sectional studies]
Lowel H, Meisinger C, Heier M, Hymer H, Alte D, Volzke H., Dtsch. Med. Wochenschr. 131(46), 2006
PMID: 17096304
Prevalence, awareness, treatment and control of hypertension in Portugal: the PAP study.
Macedo ME, Lima MJ, Silva AO, Alcantara P, Ramalhinho V, Carmona J., J. Hypertens. 23(9), 2005
PMID: 16093910
Healthy life expectancy in 191 countries, 1999.
Mathers CD, Sadana R, Salomon JA, Murray CJ, Lopez AD., Lancet 357(9269), 2001
PMID: 11425392
Regional disparities of hypertension prevalence and management within Germany.
Meisinger C, Heier M, Volzke H, Lowel H, Mitusch R, Hense HW, Ludemann J., J. Hypertens. 24(2), 2006
PMID: 16508575
Factors associated with hypertension awareness, treatment, and control in a representative sample of the chinese population.
Muntner P, Gu D, Wu X, Duan X, Wenqi G, Whelton PK, He J., Hypertension 43(3), 2004
PMID: 14744929

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

P, Das Gesundheitswesen 61(Sonderband 2), 1999
Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study.
Psaltopoulou T, Orfanos P, Naska A, Lenas D, Trichopoulos D, Trichopoulou A., Int J Epidemiol 33(6), 2004
PMID: 15218014
Association of adult socioeconomic position with hypertension in older people.
Regidor E, Gutierrez-Fisac JL, Banegas JR, Dominguez V, Rodriguez-Artalejo F., J Epidemiol Community Health 60(1), 2006
PMID: 16361458

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

H, 2000

M, Das Gesundheitswesen 61(Sonderheft 2), 1999

AUTHOR UNKNOWN, 0

HA, Hypertension 13(5 Suppl), 1989
[Trends in prevalence, awareness, treatment and control of hypertension in middle-aged Chinese population].
Wang ZW, Wu YF, Zhao LC, Li Y, Yang J, Zhou BF; Co-Operative Research Group of the Study on Trends of Cardiovascular Diseases in China And Preventive Strategy for the 21st Century., Zhonghua Liu Xing Bing Xue Za Zhi 25(5), 2004
PMID: 15231166

J, Das Gesundheitswesen 61(Sonderheft 2), 1999
Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.
Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F., JAMA 289(18), 2003
PMID: 12746359
2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension.
Whitworth JA; World Health Organization, International Society of Hypertension Writing Group., J. Hypertens. 21(11), 2003
PMID: 14597836

AUTHOR UNKNOWN, 0

AUTHOR UNKNOWN, 0

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 21735118
PubMed | Europe PMC

Suchen in

Google Scholar